JBMA.NS(JBMA.NS)
JBMA.NS
No analyst ratings available
No analyst price targets available for JBMA.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.75B | $6.40B | $8.32B | $8.93B | $8.66B | $8.98B | $10.05B | $10.60B |
| Low | $5.75B | $6.40B | $8.32B | $8.93B | $8.66B | $8.98B | $10.05B | $10.60B |
| High | $5.75B | $6.40B | $8.32B | $8.93B | $8.66B | $8.98B | $10.05B | $10.60B |
| EBITDA Avg | $725M | $807M | $1.05B | $1.13B | $1.09B | $1.13B | $1.27B | $1.34B |
| Low | $725M | $807M | $1.05B | $1.13B | $1.09B | $1.13B | $1.27B | $1.34B |
| High | $725M | $807M | $1.05B | $1.13B | $1.09B | $1.13B | $1.27B | $1.34B |
| EBIT Avg | $561M | $624M | $812M | $871M | $845M | $877M | $981M | $1.03B |
| Low | $561M | $624M | $812M | $871M | $845M | $877M | $981M | $1.03B |
| High | $561M | $624M | $812M | $871M | $845M | $877M | $981M | $1.03B |
| Net Income Avg | $85M | $222M | $350M | $390M | $355M | $319M | $863M | $272M |
| Low | $85M | $222M | $350M | $390M | $355M | $319M | $863M | $272M |
| High | $85M | $222M | $350M | $390M | $355M | $319M | $863M | $272M |
| EPS Avg | $0.36 | $0.94 | $1.48 | $1.65 | $1.50 | $1.35 | $3.65 | $1.15 |
| Low | $0.36 | $0.94 | $1.48 | $1.65 | $1.50 | $1.35 | $3.65 | $1.15 |
| High | $0.36 | $0.94 | $1.48 | $1.65 | $1.50 | $1.35 | $3.65 | $1.15 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |